Home > Insider Trading > Filing (0001209191-20-003162)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1724344	Entasis Therapeutics Holdings Inc.	ETTX	()	4

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1341382	N James Topper	C/O Entasis Therapeutics Holdings Inc. 35 Gatehouse Drive Waltham MA 02451	No	No	Yes	No
1365617	J Patrick Heron	601 Union Street, Suite 3200 Seattle WA 98101	No	No	Yes	No
1655827	Frazier Life Sciences Viii, L.p.	601 Union Street, Suite 3200 Seattle WA 98101	No	No	Yes	No
1698755	Fhm Life Sciences Viii, L.p.	601 Union Street, Suite 3200 Seattle WA 98101	No	No	Yes	No
1698823	Fhm Life Sciences Viii, L.l.c.	601 Union Street, Suite 3200 Seattle WA 98101	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2020-01-09	50,000	$5.00	1,299,953	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.00 to $5.07, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 1 to this Form 4
The reportable securities are held directly by Frazier Life Sciences VIII, L.P. ("FLS LP"). FHM Life Sciences VIII, L.P. ("FHM LP") is the general partner of FLS LP. FHM Life Sciences VIII, L.L.C. ("FHM LLC") is the general partner of FHM LP. James Topper and Patrick Heron are the sole managing members of FHM LLC. Mr. Heron, Mr. Topper, FHM LP and FHM LLC disclaims beneficial ownership of the securities held by FLS LP except, to the extent of his or its pecuniary interest therein, if any.